Bharat Biotech Ankleshwar plant gets Govt nod for Covaxin production

Published On 2021-08-11 06:19 GMT   |   Update On 2021-08-11 06:19 GMT

New Delhi: Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin."Govt of India approves vaccine manufacturing facility for production of @BharatBiotech''s #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted.The approval would help increase availability of COVID-19 vaccines...

Login or Register to read the full article

New Delhi: Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin.

"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech''s #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted.

The approval would help increase availability of COVID-19 vaccines in the country, he added.

"Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted.

Read also: Bharat Biotech facility augmentation, 3 PSUs being supported for enhancing Covaxin production: Govt

In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility.

The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.

Read also: Canadian health regulator actively reviewing Covaxin data, says Bharat Biotech US, Canada partner



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News